XNYS
WD
Market cap1.72bUSD
Jul 09, Last price
49.98USD
1D
1.44%
1Q
6.82%
Jan 2017
60.19%
IPO
409.48%
Name
Walker & Dunlop Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Walker & Dunlop, Inc., operating through its subsidiaries, offers a comprehensive range of financial products and services tailored for real estate owners and developers throughout the United States. The company specializes in financing for multifamily and various other commercial real estate ventures. Their core offerings include a diverse portfolio of loan products such as first mortgages, second trust deeds, supplemental financing, construction loans, mezzanine debt, preferred equity, small-balance loans, and bridge/interim financing. They are particularly active in multifamily finance, supporting properties like manufactured housing communities, student housing, affordable housing, and senior housing, often leveraging Fannie Mae's DUS program. Additionally, they provide both construction and permanent loans for multifamily, affordable, senior living, and healthcare facilities. Beyond direct lending, Walker & Dunlop acts as a crucial conduit, connecting commercial real estate owners with a wide array of institutional capital providers. These sources include life insurance companies, investment banks, commercial banks, pension funds, CMBS conduits, and other institutional investors. In this intermediary role, the firm offers expertise in capital structure advisory, crafts bespoke financing packages, facilitates negotiations between parties, coordinates due diligence, and guides transactions through to completion. Further expanding its service array, the company also provides property sales brokerage, robust underwriting and risk management solutions, and comprehensive loan servicing and asset management. Established in 1937, Walker & Dunlop, Inc. is headquartered in Bethesda, Maryland.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||